Cenitz
Overview
Cenitz is a France-based venture capital firm that specializes in early-stage and growth technology companies, with a focus on the greentech, medtech, and SaaS sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Axoltis Pharma | Dec 2025 | Series A | Lead |
| Askel Healthcare | May 2023 | Crowdfunding | Lead |
| Primaa | Nov 2024 | VC Round | Co-investor |
| Pandobac | Apr 2026 | VC Round | Co-investor |
| Oria Bioscience | Jun 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cenitz based?
Cenitz is headquartered in Neuilly-sur-Seine, France.
When was Cenitz founded?
Cenitz was founded in 2021.
How many portfolio companies does Cenitz have?
Cenitz has 8 portfolio companies in Caplight's dataset.
What are some companies in Cenitz's portfolio?
Portfolio companies visible on Caplight include Axoltis Pharma, Askel Healthcare, Primaa, Pandobac, Oria Bioscience.
What was Cenitz's most recent investment shown here?
Cenitz's most recent investment in this portfolio sample was in Pandobac in 2026.
What sectors does Cenitz focus on?
Cenitz focuses on Mobility, Transportation & Logistics, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Cenitz focus on?
Cenitz typically invests at the Early stage.